Business Analysis for Diabetic Products

Diabetes has become a matter of huge concern as it is a cosmopolitan disorder with an estimated 285 million diabetic, corresponding to 6.4 percentage of world’s adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 percentage of the adult population. The rate of this disorder is on it’s highest at increase. As it is a leading problem globally there is also a gigantic demand for the diagnosis and screening, medication. The global type 2 diabetes market is set to almost double from $31.2 billion in 2015 to $58.7 billion by 2025, representing a compound annual growth rate of 6.5%, according to research and consulting firm Global Data.

The pharmaceutical business is attaining a top places in this field of medication.   

  • Insulin biosimilars development
  • Novel paradigms

Related Conference of Business Analysis for Diabetic Products

July 17-18, 2017

18th European Diabetes Congress

Lisbon, Portugal
July 20-22, 2017

19thAsia Pacific Diabetes Conference

Melbourne, Australia
July 24-26,2017

10th Diabetologists Conference

Vancouver, Canada
September 20-22, 2017

International Conference on Diabetes and Diabetic Nursing Care

Charlotte, North Carolina, USA
October 30- November 1, 2017

9th Annual Congress on Endocrine Disorders and Therapies

(10 Plenary Forums - 1 Event)
Chicago, Illinois, USA
December 04-05, 2017

25th Global Diabetes Summit and Medicare Expo

Dubai, UAE
October 30-November 01, 2017

10th International Conference on Endocrinology

Chicago, Illinois, USA
February 12-13,2018

7th European Diabetes and Endocrinology Congress

Munich, Germany

Business Analysis for Diabetic Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in